Protein Expression Market Size, Trend, Forecast Report 2026 to 2035

What is Protein Expression Market Size?

Global Protein Expression Market Size is valued at USD 3.05 Bn in 2025 and is predicted to reach USD 7.03 Bn by the year 2035 at an 9.0% CAGR during the forecast period for 2026 to 2035.

Protein Expression Market, Share & Trends Analysis Report, By Type of Protein Expression System (Algal, Cell-free, Insect, Mammalian, Prokaryotic and Yeast), Protein Expression-related Offerings (Competent Cells, Expression Vectors, Instruments, Kits and Reagents, and Protein Expression Services), Application Aera, End-Users, Type of Operation, By Region and Segment Forecasts, 2026 to 2035.

The technique of creating an artificial protein, known as a heterologous protein, involves introducing recombinant DNA into a host cell, a process that exemplifies the essential biological function of protein expression. This fundamental process is so critical that even the simplest prokaryotic organisms dedicate nearly 80% of their energy and over half of their dry weight to it. Cells, as the basic building blocks of life, must synthesize proteins using the instructions encoded in their DNA, as these proteins determine their unique shapes and structures. According to the fundamental dogma of molecular biology, genetic information flows from DNA to RNA through transcription and is then translated into proteins, highlighting the intricate connection between genetics and cellular function.

In June 2024, the Broad Institute unveiled a groundbreaking epigenetic editing method capable of permanently silencing the gene responsible for producing prion proteins in the brain using molecular tools. This innovative approach, which involves a single intravenous injection of a modified adeno-associated virus (AAV), has shown promising results in animal studies, reducing prion protein levels by over 80%, and potentially paving the way for new treatments for prion diseases. In a related development, the FDA approved fifty new medications in 2021, including fourteen biologics—such as monoclonal antibodies, pegylated proteins, hormones, and enzymes—all of which require protein expression. Notably, the approval of upheld, a co-packaged preventive treatment, and various monoclonal antibodies like tocilizumab and sotrovimab for COVID-19 further highlighted the importance of protein biologics. As the FDA was expected to approve several additional medications in 2022, the growing demand for these products has significantly increased the need for protein expression goods and services, driving market expansion.

Competitive Landscape

Some of the Major Key Players in the Protein Expression Market are

• Agilent Technologies
• Ajinomoto Bio-Pharma Services
• Aldevron
• Artes Biotechnology Gmbh
• Bio-Rad Laboratories
• Bioneer Corporation
• Cayman Chemical
• Charles River Laboratories
• Corning Incorporated
• Domainex
• Danaher Corporation
• Eurofins Calixar
• Fujifilm Irvine Scientific, Inc.
• Genext Genomics
• Genscript Biotech
• Lonza
• Lucigen Corporation
• Lifesensors Inc
• Leading Biology, Inc.
• Merck Kgaa
• New England Biolabs
• Oxford Expression Technologies
• Promab
• Promega
• Proteogenix
• Peak Proteins Ltd
• Qiagen
• Sartorius
• Synbio Technologies
• Syngene
• Synthetic Genomics Inc
• Sino Biological Inc
• Jena Bioscience
• Takara Bio
• Thermo Fisher Scientific
• Wuxi Biologics

Market Segmentation

The Protein Expression Market is segmented based on the type of protein expression system, protein expression-related offerings, application area, end-users, and type of operation. Based on the type of protein expression system, the market is divided into algal, cell-free, insect, mammalian, prokaryotic, and yeast. Based on the Protein Expression-related Offerings, the market is divided into competent cells, expression vectors, instruments, kits and reagents, and protein expression services.  The market is categorized into academic and research institutes, CROS and CDMOS, pharmaceutical/biotechnology companies, and other end-users based on the end user. Based on the application area, the market is categorized into research and diagnostics, and therapeutics. Based on the type of operation, the market is categorized into In-house and outsourced operations.

The Prokaryotic Expression Systems Segment is Expected to Have the Highest Growth Rate During the Forecast Period

Based on the type of protein expression system, the market is divided into algal, cell-free, insect, mammalian, prokaryotic, and yeast. Among these, prokaryotic expression systems (particularly Escherichia coli) typically drive and hold the largest share of the protein expression market. his is due to their simplicity, cost-effectiveness, high yield, and rapid production rates. Prokaryotic systems are widely used in research and industrial applications to produce recombinant proteins. However, as the demand for more complex proteins grows, other systems like mammalian and yeast expression systems are also gaining significance for their ability to produce proteins with proper post-translational modifications. The ease of scaling up production in prokaryotic systems enables industrial-level protein manufacturing, making them ideal for large-scale applications like enzyme production, research, and biopharmaceuticals.

The Kits and Reagents Segment Dominates the Market

Based on the protein expression-related offerings, the market is divided into competent cells, expression vectors, instruments, kits and reagents, and protein expression services. Among these, kits and reagents dominate the protein expression market. This is because bio-experiments typically require a large volume of reagents for various steps in the protein production process. Reagents are crucial for every stage of protein expression, including cell preparation, vector transformation, and protein isolation. The high demand for these essential components, combined with their repeated use in experiments, makes them the largest revenue-generating segment in the protein expression market. Additionally, the growing need for reagents in both research and industrial applications further drives their dominance in the market.

North America Has the Largest Market Share During the Forecast Period.

North America, particularly the United States, is home to a highly developed biotechnology and pharmaceutical sector. Leading companies and research institutions in these fields are driving demand for protein expression technologies for drug development, biologics, and biosimilars. The region benefits from substantial investment in R&D from both government bodies and private organizations.

This funding supports innovations in protein expression systems, enhancing productivity and fostering new therapeutic applications. The rising incidence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, in North America creates a high demand for protein-based therapeutics like monoclonal antibodies and vaccines, fueling the protein expression market.

Recent Developments:

• In June 2024, Syngene International Ltd., A protein production platform was introduced by a global contract research, development, and manufacturing organization (CRDMO) to facilitate rapid production. The platform makes use of transposon- and cell line-based technology licensed from ExcellGene, a biotech services business with headquarters in Switzerland.

• In July 2024, Agilent Technologies Inc., announced at the Singapore Cell and Gene Therapy Pan Asia Summit (SCGT) the debut of its new ProteoAnalyzer system in addition to improvements to its current line of products. The automated parallel capillary electrophoresis (CE) solution from Agilent is a revolutionary protein analysis platform that combines quick, high-resolution analysis with less sample consumption. This facilitates the analysis of intricate protein blends by researchers, leading to expedited discoveries in the fields of pharma, biopharma, and bioengineered food ingredients.

Protein Expression Market Report Scope :